Nitta, Sayuri
Asahina, Yasuhiro
Kato, Takanobu
Tsuchiya, Jun
Inoue-Shinomiya, Emi
Sato, Ayako
Tsunoda, Tomoyuki
Miyoshi, Masato
Kawai-Kitahata, Fukiko
Murakawa, Miyako
Itsui, Yasuhiro
Nakagawa, Mina
Azuma, Seishin
Kakinuma, Sei
Hikita, Hayato
Takehara, Tetsuo
Watanabe, Mamoru
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18fk0210002, JP18fk0210025, JP18fk0210021))
Article History
Received: 2 November 2018
Accepted: 25 March 2019
First Online: 5 April 2019
Competing Interests
: Dr. Yasuhiro Asahina and Dr. Sei Kakinuma belong to a donation-funded department funded by Toray Industries Inc., Gilead Sciences, AbbVie GK, Chugai Pharmaceutical Co. Ltd., Fujirebio Inc. and Merck Sharp & Dohme. Dr. Mamoru Watanabe received research support from the following, Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eisai Co., Ltd., Otsuka Pharma Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Zeria Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Asahi Kasei Kuraray Medical Co., Ltd., EA Pharma Co., Ltd., AbbVie GK, Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Toray Industries, Inc, MSD K.K., Chugai Pharmaceutical Co., Ltd., Gilead Sciences, Nippon Kayaku Co., Ltd., Mochida Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Ayumi Pharmaceutical Co., Shionogi & Co., Ltd. Dr. Tetsuo Takehara has received grants from Chugai Pharmaceutical Co. Ltd., Bristol‐Myers Squibb, MSD K.K., AbbVie Inc. and Gilead Sciences. Dr. Tetsuo Takehara is on the speakers’ bureau for Bristol‐Myers Squibb, MSD K.K., AbbVie Inc. and Gilead Sciences. Dr Hayato Hikita has received grants from MSD K.K.